Epsilon Healthcare Ltd (ASX: EPN) Share Price and News

Price

Movement

( )

(20 mins delayed)

52 Week Range

-

 
1 Year Return

 

Epsilon Healthcare Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $7.21 million
P/E Ratio N/A
Dividend Yield 0.00%
Shares Outstanding 345.35 million
Earnings per share -0.006
Dividend per share N/A
Year To Date Return N/A
Earnings Yield N/A
Franking -
Share Price

Day Change

( )

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

  • Epsilon Healthcare Ltd (ASX: EPN)
    Latest News

    a woman
    Share Gainers

    Why Kogan, LiveTiles, Speedcast, & THC Global shares climbed higher today

    The LiveTiles Ltd (ASX:LVT) share price and the THC Global Group Ltd (ASX:THC) share price are two of four climbing…

    Read more »

    a woman
    Share Gainers

    Why these ASX cannabis shares are rocketing higher today

    The MGC Pharmaceuticals Ltd (ASX:MXC) share price and the THC Global Group Ltd (ASX:THC) share price are two of four…

    Read more »

    a woman
    52-Week Lows

    Why Flight Centre and these ASX shares just dropped to 52 week lows

    The Flight Centre Travel Group Ltd (ASX:FLT) share price is one of three that dropped to 52-week lows yesterday. Here’s…

    Read more »

    a woman
    Share Gainers

    Why this ASX cannabis stock has climbed 2% higher this morning

    The THC Global Group Ltd (ASX: THC) share price has climbed 2% higher in early trade after a key strategic…

    Read more »

    a woman
    Share Market News

    Here's how these ASX cannabis shares have performed in 2019

    It has been a reasonably disappointing year for AusCann Group Holdings Ltd (ASX:AC8), Cann Group Ltd (ASX:CAN), and many other…

    Read more »

    a woman
    Investing

    Can these ASX pot stocks deliver growth in 2019?

    Although it seems like the wind has gone out of the sails of many of the Australian-based pot stocks, I…

    Read more »

    a woman
    Share Fallers

    Cann Group Ltd (ASX:CAN) and the rest of the cannabis industry are being smoked today

    Cann Group Ltd (ASX:CAN) shares and the rest of the cannabis industry are being smoked today. Here's what you need…

    Read more »

    a woman
    Share Market News

    How did these local pot stocks react to Canada legalising cannabis?

    Canada became the second country in the world to legalise recreational weed last week, beginning a national experiment that could…

    Read more »

    a woman
    Share Gainers

    Why these cannabis shares smoked the market on Tuesday

    Cannabis shares BOD Australia Ltd (ASX:BDA), Hydroponics Company Ltd (ASX:THC), and MGC Pharmaceuticals Ltd (ASX:MXC) smoked the market on Tuesday...

    Read more »

    a woman
    Investing

    Are Aussie pot stocks set to smoke the market in October?

    When California started selling recreational marijuana in January, Aussie pot stocks lit up the market. Can we expect the same…

    Read more »

    a woman
    Investing

    Up in smoke: What happened to the ASX pot stocks?

    ASX pot stocks have taken a hit. Will they recover?

    Read more »

    a woman
    Share Market News

    Insiders have been buying these 3 ASX shares

    Sigma Healthcare Ltd (ASX:SIG) shares are one of three being snapped up by insiders this week. Here's what you need…

    Read more »

    EPN ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size

    About Epsilon Healthcare Ltd

    Epsilon Healthcare Ltd. manufactures and distributes hydroponics equipment, materials, and nutrients; and develops and delivers medical cannabis. The company was founded on August 29, 2016 and is headquartered on Millers Point, Australia.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Alan Preston Beasley Non-Executive DirectorNon-Executive Deputy Chairman Aug 2016
    Mr Beasley is a company director with over 30 years' experience, having served many small, medium and large company Boards including startups, IPOs and turnarounds. A former director of the Australian subsidiaries of Bankers Trust, Goldman Sachs and BNP Paribas, Alan has the corporate reach, expertise and experience to advise and assist the company in the corporate and capital markets environment. Alan also served on the ASX listings appeals committee and thus very familiar with the listing rules and requirements of the ASX, corporate governance and compliance.
    Mr Peter Giannopoulos Chief Executive OfficerExecutive Director May 2023
    Mr Giannopoulos brings more than 25 years' experience across the Australian healthcare ecosystems including proven success within the ASX healthcare setting and demonstrable success in leadership, operations, M&A, GMP manufacturing & the delivery of innovative revenue accretive opportunities. Previously Peter was CEO of Cell Therapies Pty Ltd, an Australian based globally active commercial contract development and manufacturing company with a specialisation in cell and gene therapies and cellular immunotherapy products. Peter also has a clinical background with a degree in pharmacy and a deep understanding of the Australian and international financial and operational health landscapes.
    Ms Zoe Hutchings Non-Executive Director Jun 2024
    Ms Hutchings has forged a career leading pharmaceutical and healthcare business units to identify opportunities for diversification, growth and to realise long term profitability in multiple geographical jurisdictions. Her leadership of the company-wide strategy at Sandoz, encompassing a start- up business unit and cross-company strategy, led to a return to margin accretive growth. Working within the healthcare setting has provided the opportunity to work within a highly regulated market and enabled Zoe to develop strong financial and operational governance, strategy development, and organisational advocacy. Zoe has been driven by a passion to improve health outcomes by creating earlier and expanded access to medicines. Most recently Zoe has completed a Master of Sustainability at the University of Sydney, specialising in sustainable development in business, population health, food and water security, law and policy. Concurrently, Zoe has extensive skills acquired in the pharmaceutical and healthcare industry in multi-product franchises, at various product life cycle stages from launch to patent expiry, to established generic portfolios.
    Mr Richard Phillip Legge Company Secretary Aug 2024
    -
    Mr Marcelo Mora Company Secretary Dec 2022
    -
    Richard Phillip Legge Company Secretary
    -
    Marcelo Mora Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Watercrest Asset Management Pty Ltd 35,828,878 10.37%
    Mr Craig Graeme Chapman <Nampac Discretionary A/C> 10,911,556 3.16%
    Cyrene Holdings Pty Ltd <Cyrene A/C> 10,771,121 3.12%
    Mr Alan Preston Beasley 10,500,000 3.04%
    Consolidated Nominees Pty Ltd <The Robair Investment A/C> 10,000,000 2.90%
    Dash & Co Assets Pty Ltd <Dash And Co Super Fund A/C> 10,000,000 2.90%
    Fennell Church Pty Limited <Fennell Church Prop Unit A/C> 8,438,499 2.44%
    Health360 Investment Management Inc 7,052,880 2.04%
    Giannopoulos Superannuation Nominees Pty Ltd <Giannopoulos Super Fund A/C> 7,000,000 2.03%
    Alexander Hotel Investments Pty Ltd 6,250,000 1.81%
    Cannim Group Pty Ltd 5,555,556 1.61%
    Mr Lloyd Stafford Taylor 5,318,328 1.54%
    Barcoo Holdings Pty Ltd <Wyan Family Investments> 3,795,824 1.10%
    Karantzias Investments Pty Ltd <Karantzias Family A/C> 3,636,364 1.05%
    BNP Paribas Nominees Pty Ltd <Ib Au Noms Retailclient> 3,147,900 0.91%
    Mr George Daaboul 3,000,000 0.87%
    Htgr Investments Pty Ltd 2,955,700 0.86%
    Meta Growth Corp 2,942,489 0.85%
    Celtic Capital Pty Ltd 2,888,872 0.84%
    Tiger Pty Ltd <Tiger Commercial Unit Trust> 2,545,455 0.74%

    Profile

    since

    Note